U.S., Dec. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07269704) titled 'Effect of Nutritional Supplement Alpha-ketoglutarate for Age-related Ocular Disease' on Nov. 25.
Brief Summary: The aims of the study are as follows:
1. Determine how the eye absorbs supplements taken orally.
2. Look for specific signs in the proteins and substances in the eyes of people with eye diseases who are also taking nutritional supplements.
Study Start Date: Aug. 15, 2023
Study Type: INTERVENTIONAL
Condition:
Eye Diseases
Intervention:
DRUG: Calcium alpha-ketoglutarate
Participants took 2 g/day of calcium alpha-ketoglutarate orally, twice daily, for 7 days.
Recruitment Status: COMPLETED
Sponsor: Stanford Universit...